IGM Biosciences, Inc. (IGMS) News & Overview - Discounting Cash Flows
IGMS
IGM Biosciences, Inc.
IGMS (NASDAQ)

IGMS's Business Model

IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non-Hodgkin's lymphoma (NHL). It is also developing IGM-8444, an IgM antibody, which is in Phase 1 clinical trials for the treatment of patients with solid cancers; and IGM-7354, an anti-PD-L1 IgM antibody for the treatment of patients with solid and hematologic malignancies; IGM-2644, a bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins for the treatment of patients with multiple myeloma; and IGM-2537, a bispecific T cell engaging IgM antibody targeting CD123 and CD3 proteins for the treatment of patients with acute myeloid leukemia, myelodysplastic syndromes, and acute lymphoblastic leukemia. It has a collaboration and license agreement with Genzyme Corporation to generate, develop, manufacture, and commercialize IgM antibodies. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California.
Sector & Industry Healthcare / Biotechnology
Website https://igmbio.com
CEO (Chief Executive Officer) Mary Beth Harler
Number of Employees
IPO date September 18, 2019

IGMS Latest News

Contact
CountryUS
Address325 East Middlefield Road
CityMountain View
StateCA
Phone650 965 7873
Zip Code94043
Other Identifiers
CIK0001496323
ISINUS4495851085
CUSIP449585108
Open1.35
Previous Close1.36
Volume481.6 Thou.
Average Volume506.8 Thou.
Day’s Range1.35 – 1.365
52 Week Range0.92-22.5
MA (50)1.2398
MA (200)5.21238
Market Cap81.16 Mil.
Shares Out.60.12 Mil.
Earnings DateAug 14, 2025
Beta
Last Dividend
EPS
PE

Industry Competitors for IGMS

discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us